Neil Faulkner

Statistics

Publications

Citations

211

H-Index

Active since

2013

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Neil Faulkner is an author at The Barbara Ann Karmanos Cancer Institute specializing in pre-ribosomal rna splicing, messenger ribonucleic acid delivery, and dose escalation.

Publications per year

2013–2013

Publications

A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors

David S. Hong, Razelle Kurzrock, Aung Naing et al. · Investigational New Drugs · 2013 · 211 citations

Medicine, Oncology, Pharmacology +15

1–1 of 1